Faes Farma, S.A. (BME:FAE)

Market Cap	1.40B
Revenue (ttm)	543.77M
Net Income (ttm)	105.34M
Shares Out	311.26M
EPS (ttm)	0.34
PE Ratio	13.38
Forward PE	15.82
Dividend	0.16 (3.48%)
Ex-Dividend Date	Jul 3, 2025

Volume	43,458
Average Volume	135,723
Open	4.510
Previous Close	4.510
Day's Range	4.475 - 4.540
52-Week Range	3.270 - 4.730
Beta	0.36
RSI	62.05
Earnings Date	Nov 3, 2025

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,775
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.